American Journal of Epidemiology Advance Access originally published online on May 26, 2006
American Journal of Epidemiology 2006 164(1):47-55; doi:10.1093/aje/kwj187
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contribution |
Association between Personal Use of Hair Dyes and Lymphoid Neoplasms in Europe
1 Catalan Institute of Oncology, Barcelona, Spain
2 German Cancer Research Center, Heidelberg, Germany
3 Masaryk Memorial Cancer Institute, Brno, Czech Republic
4 Registre des Hémopathies Malignes de Côte d'Or, Dijon, France
5 Institute of Occupational Medicine, University of Cagliari, Cagliari, Italy
6 School of Public Health and Population Science, University College Dublin, Dublin, Ireland
7 Department of Pathology, Tampere University Hospital, Tampere, Finland
8 International Agency for Research on Cancer, Lyon, France
9 Department of Pathology, Hospital Verge de la Cinta, Tortosa, Spain
Correspondence to Dr. Silvia de Sanjosé, Servei d'Epidemiologia i Registre del Cancer, Institut d'Investigació Biomèdica de Bellvitge, Institut Catala d'Oncologia, Gran Via Km 2.7, 08907 L'Hospitalet, Barcelona, Spain (e-mail: s.sanjose{at}iconcologia.net).
Hair dyes have been evaluated as possibly being mutagenic and carcinogenic in animals. Studies of the association between human cancer risk and use of hair dyes have yielded inconsistent results. The authors evaluated the risk of lymphoid malignancies associated with personal use of hair dyes. The analysis included 2,302 incident cases of lymphoid neoplasms and 2,417 hospital- or population-based controls from the Czech Republic, France, Germany, Ireland, Italy, and Spain (19982003). Use of hair dyes was reported by 74% of women and 7% of men. Lymphoma risk among dye users was significantly increased by 19% in comparison with never use (odds ratio (OR) = 1.19, 95% confidence interval (CI): 1.00, 1.41) and by 26% among persons who used hair dyes 12 or more times per year (OR = 1.26, 95% CI: 1.00, 1.60; p for linear trend = 0.414). Lymphoma risk was significantly higher among persons who had started coloring their hair before 1980 (OR = 1.37, 95% CI: 1.09, 1.72) and persons who had used hair dyes only before 1980 (OR = 1.62, 95% CI: 1.10, 2.40). Personal use of hair dyes is associated with a moderate increase in lymphoma risk, particularly among women and persons who used dyes before 1980. Specific compounds associated with this risk remain to be elucidated.
carcinogens; case-control studies; hair dyes; lymphatic system; neoplasms; odds ratio
Abbreviations: CI, confidence interval; OR, odds ratio
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. F. Skibola, P. M. Bracci, A. Nieters, A. Brooks-Wilson, S. de Sanjose, A. M. Hughes, J. R. Cerhan, D. R. Skibola, M. Purdue, E. Kane, et al. Tumor Necrosis Factor (TNF) and Lymphotoxin-{alpha} (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium Am. J. Epidemiol., February 1, 2010; 171(3): 267 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, K. J. Hughes, S. H. Zahm, Y. Zhang, T. R. Holford, L. Dai, Y. Bai, X. Han, Q. Qin, Q. Lan, et al. Genetic Variations in Xenobiotic Metabolic Pathway Genes, Personal Hair Dye Use, and Risk of Non-Hodgkin Lymphoma Am. J. Epidemiol., November 15, 2009; 170(10): 1222 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Burnett, W. F. Bergfeld, D. V. Belsito, C. D. Klaassen, J. G. Marks Jr, R. C. Shank, T. J. Slaga, P. W. Snyder, and F. Alan Andersen Final Report on the Safety Assessment of Amino Nitrophenols as Used in Hair Dyes International Journal of Toxicology, November 1, 2009; 28(6_suppl2): 217S - 251S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Burnett, W. F. Bergfeld, D. V. Belsito, C. D. Klaassen, J. G. Marks Jr, R. C. Shank, T. J. Slaga, P. W. Snyder, Cosmetic Ingredient Review Expert Panel, and F. A. Andersen Final Amended Report on the Safety Assessment of Ammonium Thioglycolate, Butyl Thioglycolate, Calcium Thioglycolate, Ethanolamine Thioglycolate, Ethyl Thioglycolate, Glyceryl Thioglycolate, Isooctyl Thioglycolate, Isopropyl Thioglycolate, Magnesium Thioglycolate, Methyl Thioglycolate, Potassium Thioglycolate, Sodium Thioglycolate, and Thioglycolic Acid International Journal of Toxicology, July 1, 2009; 28(4_suppl): 68 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morton, S. S. Wang, W. Cozen, M. S. Linet, N. Chatterjee, S. Davis, R. K. Severson, J. S. Colt, M. A. Vasef, N. Rothman, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes Blood, December 15, 2008; 112(13): 5150 - 5160. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al. Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma Am. J. Epidemiol., June 1, 2008; 167(11): 1321 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Final Report on the Safety Assessment of 3-Methylamino-4-Nitrophenoxyethanol as Used in Hair Dyes International Journal of Toxicology, March 1, 2008; 27(2_suppl): 41 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
Final Report on the Safety Assessment of HC Red No. 7 International Journal of Toxicology, January 1, 2008; 27(1_suppl): 45 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
Annual Review of Cosmetic Ingredient Safety Assessments: 2005/2006 International Journal of Toxicology, January 1, 2008; 27(1_suppl): 77 - 142. [Full Text] [PDF] |
||||
![]() |
L. M. Morton, L. Bernstein, S. S. Wang, D. W. Hein, N. Rothman, J. S. Colt, S. Davis, J. R. Cerhan, R. K. Severson, R. Welch, et al. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma Carcinogenesis, August 1, 2007; 28(8): 1759 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C.-H. Chiu, B. J. Dave, A. Blair, S. M. Gapstur, J. S. Chmiel, A. J. Fought, S. H. Zahm, and D. D. Weisenburger Cigarette Smoking, Familial Hematopoietic Cancer, Hair Dye Use, and Risk of t(14;18)-defined Subtypes of Non-Hodgkin's Lymphoma Am. J. Epidemiol., March 15, 2007; 165(6): 652 - 659. [Abstract] [Full Text] [PDF] |
||||



